Eli Lilly and Company: Urinary Incontinence, Stress trials
The registry lists 16 Urinary Incontinence, Stress studies with Eli Lilly and Company as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 12Phase 4 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightRecruitingNCT07202884Phase 3
- Duloxetine Stress Urinary Incontinence Efficacy and Safety StudyCompletedNCT00475397Phase 3
- Efficacy and Safety Stress Urinary Incontinence StudyCompletedNCT00475358Phase 3
- To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCompletedNCT00244296Phase 4
- Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCompletedNCT00191204Phase 3
- Duloxetine in the Treatment of Stress Urinary Incontinence.CompletedNCT00191087Phase 3
- Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCompletedNCT00190996Phase 3
- Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.CompletedNCT00190905Phase 4
- Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress IncontinenceCompletedNCT00190853Phase 3
- Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)CompletedNCT00190827Phase 3
- Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNCT00190814Phase 3
- To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNCT00190645Phase 3
- To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNCT00190632Phase 3
- Efficacy and Safety of DuloxetineCompletedNCT00190619Phase 3
- Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNCT00190606Phase 2
- Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCompletedNCT00190567Phase 2